Reply to: “Skin moisturization for xerosis related to targeted anticancer therapies” - 17/06/15
Doi : 10.1016/j.jaad.2015.03.038
Johannah Valentine, MD a, Viswanath Reddy Belum, MD b, Juanita Duran, MD c, Kathryn Ciccolini, RN, BSN b, Katja Schindler, MD b, d, Shenhong Wu, MD, PhD e, f, Mario E. Lacouture, MD b, ⁎ 
a Department of Dermatology, Naval Medical Center San Diego, San Diego, California
b Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York
c Department of Dermatology, Universidad del Rosario, Bogota, Colombia
d Department of Dermatology, Medical University of Vienna, Vienna, Austria
e Division of Hematology and Oncology, Stony Brook University Cancer Center, Stony Brook, New York
f Division of Hematology and Oncology, Department of Medicine, Northport VA Medical Center, Northport, New York
∗Correspondence to: Mario E. Lacouture, MD, Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 60th Street Outpatient Center, Suite 407, Room 4312, 16 East 60th St, New York, NY 10022
Le texte complet de cet article est disponible en PDF.
| Funding sources: Memorial Sloan Kettering Cancer Center. |
|
| Conflicts of interest: Drs Johannah Valentine, Viswanath Reddy Belum, Juanita Duran, and Katja Schindler have no conflicts of interest to declare. Kathryn Ciccolini is a speaker for Amgen. Dr Shenhong Wu is a speaker, consultant, or advisor for Novartis, Dendeon, Medivation, Bayer-Onyx, and Pfizer. Dr Mario E. Lacouture is a speaker, consultant, or advisor for Advancell, Amgen, AstraZeneca, Augmentium, Aveo, Bayer, Berg Pharma, Biopharm Communications, Boehringer Ingelheim, Brickell Biotech, Bristol-Myers Squibb, Clinical Assistance Programs, Clinical Care Options, EMD Serono, Envision Communications, Foamix, Galderma, Genentech, GlaxoSmithKline, Helsinn, Institute for Medical Education and Research, Integro-MC, Lindi Skin, Medscape, Medtrend International, Merck, Nerre Therapeutics, Novartis, Novocure, Oncology Specialty Group, OSI Pharmaceuticals, Permanyer, Physicians Education Resource, Pierre Fabre, Pfizer, Reata Pharmaceuticals, Roche, Sandoz, Sanofi Aventis, and Threshold Pharmaceuticals. |
|
| The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the US government. Dr Johannah Valentine is a military service member. This work was prepared as part of her official duty. Title 17, USC, § 105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17, U.S.C. § 101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties. |
© 2015
Publié par Elsevier Masson SAS.
Vol 73 - N° 1
P. e35-e36 - juillet 2015 Retour au numéro
Article précédent
- Skin moisturization for xerosis related to targeted anticancer therapies
- Paolo Gisondi, Giampiero Girolomoni
- Familial frontal fibrosing alopecia
- Christos Tziotzios, David A. Fenton, Catherine M. Stefanato, John A. McGrath
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?